Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Nagler RM – Saliva testing, a non–invasive alternative to serum testing, may be an effective modality for diagnosis and for prognosis prediction of oral cancer, as well as for monitoring post therapy status. At this point however, the aim of salivary analysis is mainly for screening which may be helpful in the future.

Related Articles

Oral cancer and polymorphism of ethanol metabolising genes
Oral Oncology, 11/12/09    Relevance Score: 70%

Quantification of betel quid chewing and cigarette smoking in oral cancer patients
Community Dentistry and Oral Epidemiology, 11/17/09    Relevance Score: 69%

Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer
International Journal of Cancer, 11/10/09    Relevance Score: 68%

Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer
Journal of Clinical Oncology, 10/16/09    Relevance Score: 68%

Chemoradiation for patients with advanced oral cavity cancer
The Laryngoscope, 10/27/09    Relevance Score: 67%

Today in Diagnostics/Radiology...keeping you current

Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI)
Journal of Hematology & Oncology, 11/25/09

Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours
Clinical and Translational Oncology, 11/25/09

Prognostic and predictive factors and genetic analysis of early breast cancer
Clinical and Translational Oncology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address